Methods for treatment comprising an antibody that binds CD223 protein

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10787513
APP PUB NO 20160108121A1
SERIAL NO

14973806

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Anti-CD223 antibodies overcome immune suppression in cancer patients. The anti-CD223 antibodies may be generated in an animal by injection of fragments of CD223. Antibodies may be monoclonal antibodies or single chain antibodies or humanized antibodies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ST JUDE'S CHILDREN'S RESEARCH HOSPITAL INC262 DANNY THOMAS PLACE MEMPHIS TN 38105

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Drake, Charles Baltimore, US 10 152
Huang, Ching-Tai Taipei, TW 10 150
Pardoll, Drew M Brookeville, US 68 1050
Powell, Jonathan Baltimore, US 26 195
Vignali, Dario A Pittsburgh, US 8 149
Workman, Creg J Memphis, US 8 126

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 29, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 29, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00